These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19624560)

  • 1. Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation.
    Van Laecke S; Van Biesen W; Verbeke F; De Bacquer D; Peeters P; Vanholder R
    Am J Transplant; 2009 Sep; 9(9):2140-9. PubMed ID: 19624560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes.
    Osorio JM; Bravo J; Pérez A; Ferreyra C; Osuna A
    Transplant Proc; 2010 Oct; 42(8):2910-3. PubMed ID: 20970568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients.
    Hayes W; Boyle S; Carroll A; Bockenhauer D; Marks SD
    Pediatr Nephrol; 2017 May; 32(5):879-884. PubMed ID: 28039534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
    Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
    Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between pretransplant magnesemia and the risk of new onset diabetes after transplantation within the first year of kidney transplantation.
    Augusto JF; Subra JF; Duveau A; Rakotonjanahary J; Dussaussoy C; Picquet J; Croue A; Villemain F; Onno C; Sayegh J
    Transplantation; 2014 Jun; 97(11):1155-60. PubMed ID: 24686469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
    Sinangil A; Celik V; Barlas S; Sakaci T; Koc Y; Basturk T; Akin EB; Ecder T
    Prog Transplant; 2016 Mar; 26(1):55-61. PubMed ID: 27136250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.
    Veroux M; Tallarita T; Corona D; Sinagra N; Giaquinta A; Zerbo D; Guerrieri C; D'Assoro A; Cimino S; Veroux P
    Clin Dev Immunol; 2013; 2013():496974. PubMed ID: 23762090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study.
    Yu H; Kim H; Baek CH; Baek SD; Jeung S; Han DJ; Park SK
    BMC Nephrol; 2016 Jul; 17(1):106. PubMed ID: 27473469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation.
    Huang JW; Famure O; Li Y; Kim SJ
    J Am Soc Nephrol; 2016 Jun; 27(6):1793-800. PubMed ID: 26449610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
    Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
    Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metabolic syndrome with development of new-onset diabetes after transplantation.
    Bayer ND; Cochetti PT; Anil Kumar MS; Teal V; Huan Y; Doria C; Bloom RD; Rosas SE
    Transplantation; 2010 Oct; 90(8):861-6. PubMed ID: 20724958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study.
    Lima C; Grden A; Skare T; Jaworski P; Nisihara R
    Arch Endocrinol Metab; 2018; 62(6):597-601. PubMed ID: 30624499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower magnesium level associated with new-onset diabetes and pre-diabetes after kidney transplantation.
    Garg N; Weinberg J; Ghai S; Bradauskaite G; Nuhn M; Gautam A; Kumar N; Francis J; Chen JL
    J Nephrol; 2014 Jun; 27(3):339-44. PubMed ID: 24609888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
    Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waist circumference as an independent risk factor for NODAT.
    Dedinská I; Laca Ľ; Miklušica J; Rosenberger J; Žilinská Z; Galajda P; Mokáň M
    Ann Transplant; 2015 Mar; 20():154-9. PubMed ID: 25791039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
    Reddy YN; Abraham G; Sundaram V; Reddy PP; Mathew M; Nagarajan P; Mehra N; Ramachandran A; Ali AA; Reddy YN
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
    Luan FL; Steffick DE; Ojo AO
    Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.